Literature DB >> 22864681

Genetic background, gender, age, body temperature, and arterial blood pH have a major impact on myocardial infarct size in the mouse and need to be carefully measured and/or taken into account: results of a comprehensive analysis of determinants of infarct size in 1,074 mice.

Yiru Guo1, Michael P Flaherty, Wen-Jian Wu, Wei Tan, Xiaoping Zhu, Qianhong Li, Roberto Bolli.   

Abstract

In order to determine whether the myocardial response to ischemia/reperfusion (I/R) injury varies depending on genetic background, gender, age, body temperature, and arterial blood pH, we studied 1,074 mice from 19 strains (including 129S6/SvEvTac (129S6), B6/129P2-Ptgs2(tm1Unc), B6/129SvF(2)/J, B6/129/D2, B6/CBAF1, B6/DBA/1JNcr, BALB/c, BPH2/J, C57BL/6/J (B6/J), C3H/DBA, C3H/FB/FF, C3H/HeJ-Pde6b(rd1), FVB/N/J [FVB/N], FVB/B6, FVB/ICR and Crl:ICR/H [ICR]) and distributed them into 69 groups depending on strain and: (1) two phases of ischemic preconditioning (PC); (2) coronary artery occlusion (O) time; (3) gender; (4) age; (5) blood transfusion; (6) core body temperature; and (7) arterial blood pH. Mice underwent O either without (non-preconditioned [naive]) or with prior cyclic O/reperfusion (R) (PC stimulus) consisting of six 4-min O/4-min R cycles 10 min (early PC, EPC) or 24 h (late PC, LPC) prior to 30 or 45-min O and 24 h R. In B6/J and B6/129/D2 mice, almost the entire risk region was infarcted after a 60-min O. Of the naive mouse hearts, B6/ecSOD(WT) and FVB/N mice had infarct sizes significantly smaller than those of the other mice. All strains except FVB/N benefited from the cardioprotection afforded by the early phase of PC; in contrast, development of LPC was inconsistent amongst groups and was strain-dependent. Female gender (1) was associated with reduced infarct size in ICR mice, (2) determined whether LPC developed in ICR mice, and (3) limited the protection afforded by EPC in 129S6 mice. Importantly, mild hypothermia (1 °C decrease in core temperature) and mild acidosis (0.18 decrease in blood pH) resulted in a striking cardioprotective effect in ICR mice: 67.5 and 43.0 % decrease in infarct size, respectively. Replacing blood losses with crystalloid fluids (instead of blood) during surgery also reduced infarct size. To our knowledge, this is the largest analysis of the determinants of infarct size in mice ever published. The results demonstrate that genetic background, gender, age (but not in ICR), body temperature and arterial blood pH have a major impact on infarct size, and thus need to be carefully measured and/or taken into account when designing a study of myocardial infarction in mice; failure to do so makes results uninterpretable. For example, core temperature and blood pH need to be measured, respiratory acidosis (or alkalosis) and hypothermia (or hyperthermia) must be avoided, and comparisons cannot be made between mouse strains or genders that exhibit different susceptibility to I/R injury (e.g., FVB/N male mice and ICR female mice are inherently protected against I/R injury).

Entities:  

Mesh:

Year:  2012        PMID: 22864681      PMCID: PMC3777390          DOI: 10.1007/s00395-012-0288-y

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  68 in total

1.  Epicardial temperature is a major predictor of myocardial infarct size in dogs.

Authors:  L M Schwartz; S G Verbinski; R S Vander Heide; K A Reimer
Journal:  J Mol Cell Cardiol       Date:  1997-06       Impact factor: 5.000

2.  Myocardial protection by brief ischemia in noncardiac tissue.

Authors:  B C Gho; R G Schoemaker; M A van den Doel; D J Duncker; P D Verdouw
Journal:  Circulation       Date:  1996-11-01       Impact factor: 29.690

3.  Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?

Authors:  R Gerlai
Journal:  Trends Neurosci       Date:  1996-05       Impact factor: 13.837

4.  Increased myocardial tumor necrosis factor-alpha in a crystalloid-perfused model of cardiac ischemia-reperfusion injury.

Authors:  D R Meldrum; J C Cleveland; B S Cain; X Meng; A H Harken
Journal:  Ann Thorac Surg       Date:  1998-02       Impact factor: 4.330

5.  Myocardial temperature in acute myocardial infarction: protection with mild regional hypothermia.

Authors:  S L Hale; R A Kloner
Journal:  Am J Physiol       Date:  1997-07

6.  Hypothermia extends the cardioprotection by ischaemic preconditioning to coronary artery occlusions of longer duration.

Authors:  M A van den Doel; B C Gho; S Y Duval; R G Schoemaker; D J Duncker; P D Verdouw
Journal:  Cardiovasc Res       Date:  1998-01       Impact factor: 10.787

7.  Hypothermia preserves function and signaling for mitochondrial biogenesis during subsequent ischemia.

Authors:  X H Ning; C S Xu; Y C Song; Y Xiao; Y J Hu; F M Lupinetti; M A Portman
Journal:  Am J Physiol       Date:  1998-03

8.  Altered pain perception and inflammatory response in mice lacking prostacyclin receptor.

Authors:  T Murata; F Ushikubi; T Matsuoka; M Hirata; A Yamasaki; Y Sugimoto; A Ichikawa; Y Aze; T Tanaka; N Yoshida; A Ueno; S Oh-ishi; S Narumiya
Journal:  Nature       Date:  1997-08-14       Impact factor: 49.962

Review 9.  The pH paradox in ischemia-reperfusion injury to cardiac myocytes.

Authors:  J J Lemasters; J M Bond; E Chacon; I S Harper; S H Kaplan; H Ohata; D R Trollinger; B Herman; W E Cascio
Journal:  EXS       Date:  1996

10.  Overexpression of heat shock protein 72 in transgenic mice decreases infarct size in vivo.

Authors:  J J Hutter; R Mestril; E K Tam; R E Sievers; W H Dillmann; C L Wolfe
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

View more
  19 in total

1.  Endoplasmic reticulum stress-dependent activation of ATF3 mediates the late phase of ischemic preconditioning.

Authors:  Alan C Brooks; Yiru Guo; Mahavir Singh; James McCracken; Yu-Ting Xuan; Sanjay Srivastava; Roberto Bolli; Aruni Bhatnagar
Journal:  J Mol Cell Cardiol       Date:  2014-08-23       Impact factor: 5.000

Review 2.  Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.

Authors:  Hans Erik Bøtker; Derek Hausenloy; Ioanna Andreadou; Salvatore Antonucci; Kerstin Boengler; Sean M Davidson; Soni Deshwal; Yvan Devaux; Fabio Di Lisa; Moises Di Sante; Panagiotis Efentakis; Saveria Femminò; David García-Dorado; Zoltán Giricz; Borja Ibanez; Efstathios Iliodromitis; Nina Kaludercic; Petra Kleinbongard; Markus Neuhäuser; Michel Ovize; Pasquale Pagliaro; Michael Rahbek-Schmidt; Marisol Ruiz-Meana; Klaus-Dieter Schlüter; Rainer Schulz; Andreas Skyschally; Catherine Wilder; Derek M Yellon; Peter Ferdinandy; Gerd Heusch
Journal:  Basic Res Cardiol       Date:  2018-08-17       Impact factor: 17.165

Review 3.  Ischemia/Reperfusion.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Compr Physiol       Date:  2016-12-06       Impact factor: 9.090

4.  PU.1 inhibition does not attenuate cardiac function deterioration or fibrosis in a murine model of myocardial infarction.

Authors:  Yibing Nong; Yiru Guo; Qinghui Ou; Anna Gumpert; Alex Tomlin; Xiaoping Zhu; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2022-09-17       Impact factor: 3.842

5.  The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.

Authors:  Steven P Jones; Xian-Liang Tang; Yiru Guo; Charles Steenbergen; David J Lefer; Rakesh C Kukreja; Maiying Kong; Qianhong Li; Shashi Bhushan; Xiaoping Zhu; Junjie Du; Yibing Nong; Heather L Stowers; Kazuhisa Kondo; Gregory N Hunt; Traci T Goodchild; Adam Orr; Carlos C Chang; Ramzi Ockaili; Fadi N Salloum; Roberto Bolli
Journal:  Circ Res       Date:  2014-12-11       Impact factor: 17.367

6.  Kir6.2 is not the mitochondrial KATP channel but is required for cardioprotection by ischemic preconditioning.

Authors:  Andrew P Wojtovich; William R Urciuoli; Shampa Chatterjee; Aron B Fisher; Keith Nehrke; Paul S Brookes
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

7.  NO triggers RGS4 degradation to coordinate angiogenesis and cardiomyocyte growth.

Authors:  Irina M Jaba; Zhen W Zhuang; Na Li; Yifeng Jiang; Kathleen A Martin; Albert J Sinusas; Xenophon Papademetris; Michael Simons; William C Sessa; Lawrence H Young; Daniela Tirziu
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

Review 8.  Investigating mechanisms of myopia in mice.

Authors:  Machelle T Pardue; Richard A Stone; P Michael Iuvone
Journal:  Exp Eye Res       Date:  2013-01-07       Impact factor: 3.467

9.  DNA Methylation Indicates Susceptibility to Isoproterenol-Induced Cardiac Pathology and Is Associated With Chromatin States.

Authors:  Haodong Chen; Luz D Orozco; Jessica Wang; Christoph D Rau; Liudmilla Rubbi; Shuxun Ren; Yibin Wang; Matteo Pellegrini; Aldons J Lusis; Thomas M Vondriska
Journal:  Circ Res       Date:  2016-01-11       Impact factor: 17.367

10.  Single dose of synthetic microRNA-199a or microRNA-149 mimic does not improve cardiac function in a murine model of myocardial infarction.

Authors:  Yibing Nong; Yiru Guo; Anna Gumpert; Qianhong Li; Alex Tomlin; Xiaoping Zhu; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2021-07-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.